A phase 2 multicenter open label study of ARQ 501 [beta lapachone] in adult patients with recurrent, persistent or metastatic leiomyosarcoma
Phase of Trial: Phase II
Latest Information Update: 20 Mar 2008
At a glance
- Drugs Beta lapachone (Primary)
- Indications Leiomyosarcoma
- Focus Therapeutic Use
- Sponsors ArQule
- 20 Mar 2008 Status changed from in progress to completed based on information from the ClinicalTrials.gov site.
- 24 Jan 2007 Status change
- 23 Jun 2006 New trial record.